0KHE.LSE Revvity

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
23.3x
P/B
-
ROE
2.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0KHE.LSE undervalued?

Graham number

The Graham number of Revvity cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Revvity fundamental analysis

No fundamental analysis for Revvity yet.

Revvity stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for …

Full company profile